ONE SYSTEM
So many possibilities to maximise before and after patient care

About LPG endermologie

endermologie is the patented and trademarked technology first developed in France by Louis Paul Guitay (LPG) in the 1980s and is the undisputed pioneer in the field of aesthetic medicine.

LPG endermologie has continually evolved through extensive research and development to bring you the Cellu M6 Alliance Medical device. 

Clinically proven and supported by more than 145 scientific studies, the non-invasive mechanical stimulation of connective tissue, makes for a highly effective treatment that is pleasant on the skin, reactivating the body’s natural physiological processes.

Cellu M6 Alliance Medical device – scientifically proven properties

• Natural treatment of muscular, cutaneous, and sub-cutaneous tissue
• x4 – increase in blood circulation and tissue perfusion¹
• x3 - lymphatic flow¹
• 40% - reduction in fibrosis²
• +80% - stimulation of endogenous hyaluronic acid synthesis⁴
• +46% - stimulation of endogenous collagen and elastin⁴
• 60% - reduction in pain³

LPG endermologie in conjunction with medical & aesthetic procedures

The Cellu M6 Alliance Medical is designed to treat:

• Connective tissue (burns, scars, fibrosis, etc.)
• Circulation and lymphatic drainage
• Muscle pathologies (lesions, contractures, etc.) naturally and painlessly

The Cellu M6 Alliance Medical device is loaded with >150 protocols, specifically designed with pre and post Aesthetic medicine in mind:

• Pre-liposuction double chin
• Post breast surgery optimisation
• Pre-abdominoplasty – 10min
• Post-cryo drainage waist
• Post-cryo drainage abdomen
• Post liposuction drainage arm
• Pre-injections upper third – man & woman face

One system. So many possibilities to maximise before and after patient care.

About Endotherapeutics

Endotherapeutics are 100% Australian owned with over 20 year’s experience in the medical technologies industry.

Endotherapeutics was founded in 1999 by CEO, Ivan Srejber with a small team, and a number of innovative, niche medical technologies that provided quality of life improving solutions to healthcare professionals. Since then, hard work combined with tenacity, dynamism, drive and determination has turned Endotherapeutics into a leading 100% owned Australian healthcare technologies company that operates across both Australia and New Zealand.

Over 20 years of experience has allowed Endotherapeutics to develop extensive knowledge of the Australian and New Zealand healthcare systems. This includes the registration and reimbursement of new medical technologies, and their successful sales and marketing.

Endotherapeutics extensive product portfolio spans across Urology, ENT, GI, Gynaecology and Aesthetics specialties. The aesthetics portfolio includes LPG endermologie, Tuenda LED Light Therapy and Bloomea Macro Exfoliation technologies. Endotherapeutics prides itself on its customer centric approach through ongoing product support, education and service.

References:
1. Watson I.P., Fodor P.B. et al. U.C.L.A. Los Angeles, USA Physiological Effects of endermologie®: A Preliminary Report, Aesthetic Surg. J. 1999, 19 (1); 27-33
2. Worret W.I. & Jessberger B. Dermatology Department Technical University, Munich, Germany, Effectiveness of LPG® treatment in morphea (circumscribed scleroderma), J. Eur. Acad. Dermatol. Venereol. September 2004; 18(5): 527-30 
3. Gordon C. et al. Memorial Hospital of Union, County Marysville, OH; USA, Use of a Mechanical Massage Technique in the treatment of Fibromyalgia: A Preliminary Study, Arch. Phys Med Rehabil. 2006; Jan; 87(1):145-7.
4. Humbert P. CHU Besançon, Dermatology Department, France, Mécano-stimulation – Endermolift®,  Swiss European Congress of Longevity, Aesthetic & Regenerative Medicine (SECLARM); 29, 30 & 31 May 2014 – Geneva